PT964867E - Antagonistas da taquicinima - Google Patents

Antagonistas da taquicinima

Info

Publication number
PT964867E
PT964867E PT97953927T PT97953927T PT964867E PT 964867 E PT964867 E PT 964867E PT 97953927 T PT97953927 T PT 97953927T PT 97953927 T PT97953927 T PT 97953927T PT 964867 E PT964867 E PT 964867E
Authority
PT
Portugal
Prior art keywords
taquicinima
antagonists
Prior art date
Application number
PT97953927T
Other languages
English (en)
Portuguese (pt)
Inventor
Mahavir Prashad
Christopher Simon John Walpole
Denis Har
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT964867E publication Critical patent/PT964867E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT97953927T 1997-01-14 1997-12-29 Antagonistas da taquicinima PT964867E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700597.9A GB9700597D0 (en) 1997-01-14 1997-01-14 Organic compounds

Publications (1)

Publication Number Publication Date
PT964867E true PT964867E (pt) 2005-07-29

Family

ID=10805904

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97953927T PT964867E (pt) 1997-01-14 1997-12-29 Antagonistas da taquicinima

Country Status (14)

Country Link
US (1) US6107293A (enExample)
EP (1) EP0964867B1 (enExample)
JP (2) JP4306804B2 (enExample)
AR (1) AR011521A1 (enExample)
AT (1) ATE290546T1 (enExample)
AU (1) AU5764298A (enExample)
CA (1) CA2278057C (enExample)
CO (1) CO4950614A1 (enExample)
DE (1) DE69732715T2 (enExample)
ES (1) ES2239368T3 (enExample)
GB (1) GB9700597D0 (enExample)
PT (1) PT964867E (enExample)
WO (1) WO1998031704A2 (enExample)
ZA (1) ZA98256B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426331B1 (en) 1998-07-08 2002-07-30 Tularik Inc. Inhibitors of STAT function
GB9815696D0 (en) * 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics
KR100699404B1 (ko) 1999-02-18 2007-03-23 가켄 세야쿠 가부시키가이샤 성장 호르몬 분비촉진제로서의 신규 아미드 유도체
WO2001083517A1 (en) * 2000-05-03 2001-11-08 Tularik Inc. Stat4 and stat6 binding dipeptide derivatives
US6884782B2 (en) 2000-11-08 2005-04-26 Amgen Inc. STAT modulators
US20070219214A1 (en) * 2006-02-01 2007-09-20 Solvay Pharmaceuticals Gmbh Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
US8426386B2 (en) 2006-10-16 2013-04-23 Lion Corporation NK1 receptor antagonist composition
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
RU2020131446A (ru) 2018-02-26 2022-03-28 Оспедале Сан Раффаэле С.Р.Л. Антагонисты nk-1 для применения в лечении глазной боли
EP4117673A1 (en) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Treatment of stem cell deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
FR2719312B1 (fr) * 1994-04-28 1996-06-14 Adir Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0964867B1 (en) 2005-03-09
ES2239368T3 (es) 2005-09-16
US6107293A (en) 2000-08-22
ZA98256B (en) 1998-07-14
DE69732715D1 (de) 2005-04-14
JP2000516257A (ja) 2000-12-05
AU5764298A (en) 1998-08-07
EP0964867A2 (en) 1999-12-22
JP4306804B2 (ja) 2009-08-05
DE69732715T2 (de) 2006-04-13
CA2278057A1 (en) 1998-07-23
WO1998031704A3 (en) 1998-09-11
CO4950614A1 (es) 2000-09-01
AR011521A1 (es) 2000-08-30
JP3817256B2 (ja) 2006-09-06
JP2006089499A (ja) 2006-04-06
ATE290546T1 (de) 2005-03-15
CA2278057C (en) 2004-05-04
GB9700597D0 (en) 1997-03-05
WO1998031704A2 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
EP0986385A4 (en) GONADORELIN ANTAGONISTS
DE69838845D1 (de) Zerstäuber
DE69823565D1 (de) Zerstäuber
FI972714A0 (fi) Foerfarande foer erhaollning av propenterpolymerer
FI972701A0 (fi) Foerfarande foer begraensning av anvaendning av terminaler
FI974023A0 (fi) Taetningskonstruktion foer suglaogan av en sugvals i en pappersmaskin/en kartongmaskin
FI970156A0 (fi) Foerfarande foer framstaellning av fiberplattor
FI971696A0 (fi) Foerfarande foer heat-soak-behandling av haerdade glasskivor
FI970477A0 (fi) Foerfarande foer behandling av en oevantad nedkopplingsbegaeran
DE69816500D1 (de) Kodemultiplexnachrichtenübertragungssystem
FI972800A0 (fi) Behandling av signaleringsmeddelande i ATM-nod
FI973312A0 (fi) Foerfarande foer indikering av en abonnent i en kedjad V5-anslutning
FI972533A0 (fi) Foerfarande foer styrning av bergborrning
FI973582A0 (fi) Maetning av faedningsmarginal i radiosystem
FI971222A0 (fi) Tillverkning av vaegmaerken
FI971730A0 (fi) Munstyckesarrangemang i blaoslaodan av en pappersmaskin
FI973860A0 (fi) Foerfarande foer saekerstaellande av noedkommunikation i en kedjad V5-anslutning
FI971841A0 (fi) Foerfarande foer framstaellning av bestrykningssmet foer papper
FI972847A0 (fi) Foerfarande foer hantering av aonga i en fibreringsprocess
FI970072A0 (fi) Anordning foer styrning av en lyftkrans lastningsorgan
FI974311A0 (fi) Foerfarande foer centralisering av abonnenter i en lokalcentral
FI973311A0 (fi) Foerfarande foer foermedling av protokollen foer V5-anslutningar i en kedjad V5-anslutning
FI971902A0 (fi) Foerfarande foer behandling av mjoelk
FI972711A0 (fi) Foerfarande foer bestaemning av ligninhalt i barr- och loevvedsmassa
FI972394A0 (fi) Foerfarande foer behandling av draggaser i en loesningsbehaollare av en sodapanna